Association Between Inflammatory Markers, Comorbidities, and Mortality in COVID-19 Patients Treated With Tocilizumab. Silva RMD, Soper MS, Neves JH, Maciel CEA, et al. J Med Virol 2026;98:e71028.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silva RMD, Soper MS, Neves JH, Maciel CEA, et al. Association Between Inflammatory Markers, Comorbidities, and Mortality in COVID-19 Patients Treated With Tocilizumab. J Med Virol 2026;98:e71028.
PMID: 42333746